首页> 外国专利> METHOD FOR PREVENTING ACUTE PANCREATITIS AFTER ENDOSCOPIC RETROGRADE PANCREATOCHOLANGIOGRAPHY AND ENDOSCOPIC PAPILLOSPHINCTEROTOMY

METHOD FOR PREVENTING ACUTE PANCREATITIS AFTER ENDOSCOPIC RETROGRADE PANCREATOCHOLANGIOGRAPHY AND ENDOSCOPIC PAPILLOSPHINCTEROTOMY

机译:内镜逆行胰胆管造影和内镜乳头状肠镜术后预防急性胰腺炎的方法

摘要

The method for preventing the acute pancreatitis after the endoscopic retrograde pancreatocholangiography and endoscopic papillosphincterotomy consists in the intravenous administration of Octreotid prior to papillosphincterotomy. The drug is administered in the following cases: the obesity, the ductal hypertension in the pancreatic duct in choledocholithiasis, the stenosing papillitis, the low duodenal ulcer, the location of the greater papilla in the diverticulum, the hyperplasia of the papilla, the wedging of the concrement into the papilla. After papillosphincterotomy ?-amilase is assayed in the blood. When its content exceeds 38 units, Octreotid is used daily for 2-3 days.
机译:内窥镜逆行胰胆管造影术和内窥镜乳头括约肌切开术后预防急性胰腺炎的方法包括在乳头括约肌切开术之前静脉内注射奥曲肽。在以下情况下给药:肥胖,胆总管结石的胰管导管高压,狭窄性乳头炎,十二指肠溃疡低,憩室中较大乳头的位置,乳头的增生,乳头中的粪便。乳头括约肌切开术后,在血液中测定β-酰胺酶。当其含量超过38个单位时,奥曲肽每天使用2-3天。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号